| Name | Title | Contact Details |
|---|
Anavasi Diagnostics is a medical technology company focused on saving lives by developing novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology. It was founded by world-leading university researchers, top medical device and clinical diagnostics engineering and design executives, manufacturing experts and a former Microsoft software veteran. Throughout their careers, the team has altogether been responsible for the introduction of more than forty medical/diagnostic products and over 350 peer-reviewed research publications.
PHS Technologies is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
eScan Data Systems is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.
Radiation Monitoring Devices, Inc. is a Watertown, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.